Kollman‐Bauerly et al., 2001 - Google Patents
The role of eicosanoids in the process of adaptation following massive bowel resection in the ratKollman‐Bauerly et al., 2001
View PDF- Document ID
- 9345585244756209172
- Author
- Kollman‐Bauerly K
- Thomas D
- Adrian T
- Lien E
- Vanderhoof J
- Publication year
- Publication venue
- Journal of Parenteral and Enteral Nutrition
External Links
Snippet
Background: Long chain polyunsaturated fatty acids (LCPUFAs) such as arachidonic acid (AA) and eicosapentaenoic acid (EPA) stimulate intestinal adaptation. Prostaglandins also enhance intestinal adaptation. The purpose of this study was to determine by which …
- 241000700159 Rattus 0 title abstract description 32
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/20—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids
- A61K31/202—Carboxylic acids, e.g. valproic acid having a carboxyl group bound to a chain of seven or more carbon atoms, e.g. stearic, palmitic, arachidic acids having three or more double bonds, e.g. linolenic
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
- A61K31/197—Carboxylic acids, e.g. valproic acid having an amino group the amino and the carboxyl group being attached to the same acyclic carbon chain, e.g. gamma-aminobutyric acid [GABA], beta-alanine, epsilon-aminocaproic acid, pantothenic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/22—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids of acyclic acids, e.g. pravastatin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids
- A61K31/575—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives, e.g. steroids substituted in position 17 beta by a chain of three or more carbon atoms, e.g. cholane, cholestane, ergosterol, sitosterol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Broughton et al. | Reduced asthma symptoms with n-3 fatty acid ingestion are related to 5-series leukotriene production | |
| Kollman et al. | Dietary lipids influence intestinal adaptation after massive bowel resection | |
| Shahidi et al. | Omega-3 (n-3) fatty acids in health and disease: part 1—cardiovascular disease and cancer | |
| Gassull et al. | Nutrition in inflammatory bowel disease | |
| NO333143B1 (en) | New fatty acid analogues for the treatment of diabetes | |
| Wong et al. | Colonic health: fermentation and short chain fatty acids | |
| Mohrhauer et al. | Effect of linolenic acid upon the metabolism of linoleic acid | |
| Tu et al. | Omega-3 long chain fatty acid synthesis is regulated more by substrate levels than gene expression | |
| Meijerink et al. | The ethanolamide metabolite of DHA, docosahexaenoylethanolamine, shows immunomodulating effects in mouse peritoneal and RAW264. 7 macrophages: evidence for a new link between fish oil and inflammation | |
| ES2252874T3 (en) | USE OF CONJUGATED LINOLEIC ACID FOR TREATMENT OF MELLITUS TYPE II DIABETES. | |
| Bines et al. | Influence of diet complexity on intestinal adaptation following massive small bowel resection in a preclinical model | |
| JPH08500332A (en) | Use of an emulsion for preparing a parenterally administered drug for the treatment of inflammatory diseases | |
| Sukhotnik et al. | Effect of dietary fat on early morphological intestinal adaptation in a rat with short bowel syndrome | |
| Cabré et al. | Nutrition in inflammatory bowel disease: impact on disease and therapy | |
| Kelavkar et al. | Prostate tumor growth can be modulated by dietarily targeting the 15-lipoxygenase-1 and cyclooxygenase-2 enzymes | |
| Kollman‐Bauerly et al. | The role of eicosanoids in the process of adaptation following massive bowel resection in the rat | |
| Pavlisova et al. | Chronic n-3 fatty acid intake enhances insulin response to oral glucose and elevates GLP-1 in high-fat diet-fed obese mice | |
| Vega et al. | Effect of nutritional vitamin A deficiency on lipid metabolism in the rat heart: Its relation to PPAR gene expression | |
| WO2006023342A2 (en) | Synergistic conjugated linoleic acid (cla) and carnitine combination | |
| Wang et al. | Muscle food and human health: A systematic review from the perspective of external and internal oxidation | |
| Poulsen et al. | Detrimental effect of eicosapentaenoic acid supplementation on bone following ovariectomy in rats | |
| Jacobs | Role of dietary factors in cell replication and colon cancer | |
| US7015249B1 (en) | Methods and compositions for treating diabetes | |
| Hickman | Interventional nutrition for gastrointestinal disease | |
| US20060025483A1 (en) | (-)-Hydroxycitric acid for protection against soft tissue and arterial calcification |